<unk> (Camptosar) is an antineoplastic agent that is FDA approved for the treatment of metastatic carcinoma of the colon or rectum. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting, abdominal pain, diarrhea, constipation, anorexia, mucositis, neutropenia, leukopenia (including lymphocytopenia), anemia, thrombocytopenia, asthenia, pain, fever, infection, abnormal bilirubin and alopecia.
Irinotecan hydrochloride 
Vincristine sulfate
Idoxuridine
Doxorubicin hydrochloride
Trifluridine
Floxuridine
Idarubicin hydrochloride
Epirubicin hydrochloride